Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Balloon Catheters Market Outlook

The global balloon catheters market size was valued at USD 4.5 billion in 2023, driven by the rising prevalence of cardiovascular diseases across the globe. The market is expected to grow at a CAGR of 6.5% during the forecast period of 2024-2032, with the values likely to rise from USD 4.8 billion in 2024 to USD 8.1 billion by 2032.

Key Takeaways

  • Cardiovascular disease (CVD) ranks as the leading cause of mortality globally, with recent data estimating that approximately 620 million individuals  are affected by heart and circulatory diseases.

  • In December 2023, the United States Food and Drug Administration (FDA) approved the Finesse Injectable angioplasty balloon catheters developed by Summa Therapeutics, LLC. It can be used for the percutaneous transluminal angioplasty (PTA) treatment of peripheral artery disease.

  • The rising healthcare infrastructure investments and growing demand for minimally invasive procedures are key factors elevating the balloon catheter market value.

Balloon catheters comprise an inflatable balloon at the tip which can be often used to enlarge a narrow opening during a catheterization procedure. After the inflated balloon performs the procedure, it is deflated to remove it from the body. Balloon catheters with over-the-wire (OTW) or rapid exchange (Rx) designs are often employed during angioplasty procedures.

Balloon catheters are considered pivotal in revolutionizing minimally invasive procedures. As a result, it is experiencing high demand in the market for various medical procedures, including angioplasty and stenting. The market holds high value which can be attributed to the rising prevalence of cardiovascular diseases, growing geriatric population, and the increased adoption of technologically advanced balloon catheter technologies.

Global Balloon Catheters Market Trends

The rising technological advancement, miniaturization of devices, increased application of balloon catheters in minimally invasive procedures, and the growing geriatric population comprise some of the key trends and developments in the market.

Date Company     Event
December 2023 HR Pharmaceuticals, Inc. HR Pharmaceuticals, Inc. (HRP) announced that it has signed an Exclusive Commercial Agreement with Poiesis Medical LLC, which grants HRP the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America. The dual balloon catheter technology is expected to provide better results than conventional Foley catheters. With this new addition to its urological portfolio, the company aims to improve patient outcomes and drive balloon catheters market growth.
December 2023 Summa Therapeutics, LLC The United States Food and Drug Administration (FDA) has granted approval to the Finesse Injectable angioplasty balloon catheters developed by a United States-based medical devices company, Summa Therapeutics, LLC, for the percutaneous transluminal angioplasty (PTA) treatment of peripheral artery disease including popliteal, iliac, femoral, and renal arteries, among others. The Finesse product line offers a port to inject radiopaque contrast material along with its role in performing balloon angioplasty, thus acting as an advanced toolset for angioplasty procedures.
June 2023 Translumina Therapeutics A leading interventional cardiovascular device company, Translumina Therapeutics, acquired Blue Medical Devices, a Netherlands-based medical technology manufacturer. Through this acquisition, the company expanded its intervention cardiology portfolio with Blue Medical’s next-generation Drug Coated Balloon Catheters, which will complement its next-generation drug eluting stents product line. The increasing incidence of such strategic collaborations is poised to boost the balloon catheters market share in coming years.
May 2023 Concept Medical Inc.  Concept Medical Inc. received an Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) for its novel MagicTouch Sirolimus Coated Balloon (SCB) Catheter to treat small coronary artery disease. The approval will allow the company to test the effectiveness and safety of the device in treating the condition through appropriate clinical studies. The data generated from the trials will further help in submitting a pre-market approval (PMA) application in the United States.
Key Trend Impact
Rising Technological Advancement The integration of advanced imaging technologies and pressure sensors within balloon catheters facilitates real-time feedback and precision during procedures. The demand for smart catheters is expected to rise as they improve procedural success rates, enhance safety, and offer more personalized treatments.
Miniaturization of Devices The development of smaller and more flexible balloon catheters has enabled access to challenging vascular regions. This miniaturization reduces procedural risks as well as recovery times and is likely to fuel the balloon catheter market demand in the coming years.
Increased Application in Minimally Invasive Procedures With the patient’s inclination towards minimally invasive surgical techniques, there is a rising demand for balloon catheters across various medical procedures, including angioplasty and stenting. Thus, balloon catheters play an important role in reducing surgical trauma and improving patient recovery.
Growth in Geriatric Population  The rising geriatric population, more susceptible to cardiovascular and peripheral vascular diseases, directly influences the demand for balloon catheter-based interventions. This shift necessitates the availability and development of innovative balloon catheter devices.

Global Balloon Catheters Market Growth Factors

The market is driven by the surge in novel product approvals by health regulatory agencies such as the United States Food and Drug Administration (FDA). The accelerated regulatory approvals for balloon catheter products foster accessibility and subsequent adoption of these advanced technologies in the healthcare sector. Moreover, it encourages health technology companies to invest significantly in the development of such products, which is expected to boost the balloon catheter market size.

The increased strategic partnerships among the key market players, rising healthcare spending, and heightened public awareness about cardiovascular health are likely to augment the market size for balloon catheters. Moreover, increased innovations in the material technology of balloon catheters such as the use of advanced polymers are also expected to drive market growth in the forecast period.

Global Balloon Catheters Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Market Breakup Categories
Product   Rapid Exchange (RX) Balloon Catheters, Over-The-Wire (OTW) Balloon Catheters, Drug Eluting Balloon Catheters, Stent Graft Balloon Catheters, Others
Indication Coronary Artery Disease, Peripheral Vascular Disease
End User Hospitals, Ambulatory Surgical Centers, Others
Region  North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

By product, the market includes rapid exchange (RX) balloon catheters, over-the-wire (OTW) balloon catheters, drug eluting balloon catheters, and stent graft balloon catheters, among others. The demand for balloon catheters is expected to rise owing to the rising prevalence of chronic heart diseases and increased healthcare expenditure.

In terms of indication, balloon catheters are utilized primarily in the treatment of coronary artery disease and peripheral vascular disease. These devices help in addressing blockages and narrowing of blood vessels in the heart and peripheral arteries.

By end users, the balloon catheters market share includes hospitals, ambulatory surgical centers, and other healthcare facilities where interventional procedures are performed for patients with cardiovascular conditions.

On the basis of region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Regional disparities exist in the markets depending on variables such as healthcare infrastructure, the prevalence of cardiovascular diseases, and the regulatory framework in the region.

Global Balloon Catheters Market: Competitive Landscape

The key market players are contributing to the balloon catheters market growth through innovative product launches, increased investments, and continuous research and development initiatives aimed at technological advancement.

Company Year Founded Headquarters Products/Services
Medtronic 1949 Dublin, Ireland Offers a wide range of balloon catheters for cardiovascular procedures
Boston Scientific Corporation     1979 Marlborough, Massachusetts, USA Specializes in innovative balloon catheters for coronary interventions
Abbott 1888 Abbott Park, Illinois, USA Provides various balloon catheter products for cardiovascular treatments and interventions.
Spectrum Plastics Group 1949 Alpharetta, Georgia, USA Manufactures advanced medical tubing extrusions and catheter components

Other key players in the market include Biotronik, Shanghai MicroPort Medical (Group) Co., Ltd., Artivion, Inc, B. Braun SE, Cook Group Incorporated, Becton, Dickinson and Company, Cardinal Health, Terumo Medical Corporation, Coloplast Group, Lepu Medical Technology (Beijing) Co., Ltd., and INVAMED.

Global Balloon Catheters Market Analysis by Region

North America holds a significant share of the market which can be attributed to the presence of an advanced healthcare system and increased demand for minimally invasive interventions. Further, the rising elderly population with a high risk of having heart and circulatory conditions, the surge in product approvals by regulatory bodies, and robust research and development initiatives are some of the factors that are expected to boost market growth in the forecast period.

In Europe, the balloon catheter market size is experiencing a steady expansion due to the rising prevalence of cardiovascular diseases in the region. It is estimated that around 45% of mortality in Europe is caused by cardiovascular diseases, which indicates the need for appropriate interventions such as advanced balloon catheter technology to tackle the rising disease burden. Moreover, the presence of leading marketing players and premium research institutes directly impacts the market dynamics in this regional market.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Indication
  • End-user
  • Region
Breakup by Product
  • Rapid Exchange (RX) Balloon Catheters            
  • Over-The-Wire (OTW) Balloon Catheters            
  • Drug Eluting Balloon Catheters            
  • Stent Graft Balloon Catheters        
  • Others
Breakup by Indication
  • Coronary Artery Disease            
  • Peripheral Vascular Disease     
Breakup by End-user
  • Hospitals            
  • Ambulatory Surgical Centers            
  • Others 
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Spectrum Plastics Group
  • Biotronik
  • Shanghai MicroPort Medical (Group) Co., Ltd.
  • Artivion, Inc
  • B. Braun SE
  • Cook Group Incorporated
  • Becton, Dickinson and Company
  • Cardinal Health
  • Terumo Medical Corporation
  • Coloplast Group
  • Lepu Medical Technology (Beijing)Co.,Ltd.
  • INVAMED

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 4.5 billion in 2023 driven by the rising prevalence of cardiovascular diseases across the globe.

The market is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032, likely to reach a market value of USD 8.1 billion by 2032.

Advancements in balloon catheter technology and rising healthcare expenditure are fuelling the demand for the market.

One of the significant trends in the market is the increased merger and acquisition initiatives among the key market players. In June 2023, Translumina Therapeutics, acquired a Blue Medical Devices (Netherlands-based medical technology manufacturer) to expand its intervention cardiology portfolio with Blue Medical’s next-generation drug coated balloon catheters.

Based on the product, the market is segmented into rapid exchange (RX) balloon catheters, over-the-wire (OTW) balloon catheters, drug eluting balloon catheters, and stent graft balloon catheters, among others.

Major end users include hospitals and ambulatory surgical centers, among others.

Based on indication, the market includes coronary artery disease and peripheral vascular disease.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Key players involved in the market are Medtronic, Boston Scientific Corporation, Abbott, Spectrum Plastics Group, Biotronik, Shanghai MicroPort Medical (Group) Co., Ltd., Artivion, Inc, B. BraunSE, Cook Group Incorporated, Becton, Dickinson and Company, Cardinal Health, Terumo Medical Corporation, Coloplast Group, Lepu Medical Technology (Beijing) Co., Ltd., and INVAMED.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124